Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, double-blind, phase 1/2, multicenter dose ranging study to determine the tolerability and effect on bone turnover of several monthly doses of ibandronate in postmenopausal women
ibandronate
BP16331
osteoporosis with pathological fracture
Phase 2
 
January 2014

Powered by ideaPoint, Inc.